Antoinette van Driel

Antoinette van Driel is a Researcher in the Department of General Practice at Erasmus School of Medicine, Erasmus University Rotterdam, specializing in infectious diseases within primary care. Her work centers on optimizing antibiotic therapy for urinary tract infections while addressing antimicrobial resistance challenges in community settings.

Her research interests encompass antimicrobial resistance mechanisms, clinical pharmacology of antibiotics like nitrofurantoin, and evidence-based guideline implementation in general practice. She investigates drug exposure variables including dosing regimens, renal function impacts, and age-related pharmacokinetics to improve UTI treatment efficacy.

Analysis of her 2018-2023 publications reveals persistent focus on urinary tract infection management, with studies examining nitrofurantoin pharmacokinetics, ESBL-producing bacteria surveillance, and decade-long resistance trends in Escherichia coli. Her methodology frequently combines clinical data from general practice with laboratory microbiology analysis, contributing to national treatment guideline refinement. An earlier 2010 publication demonstrates prior expertise in reconstructive surgery outcomes.

Collaborative networks include prominent researchers like E.E. Stobberingh and A. Verbon across infectious disease and clinical pharmacology disciplines, though no formal advising relationships or grant funding are documented in the source material.